Cognition Therapeutics Inc.
CogRx is a clinical-stage pharmaceutical company developing novel drugs that work through a completely new mechanism to treat or prevent Alzheimer's disease.
- Stage Product In Development
- Industry Biotechnology
- Location Pittsburgh, PA, USA
- Currency USD
- Founded August 2007
- Employees 8
- Incorporation Type C-corp
- Website CogRx.com